Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jenscare Scientific CoHKSE:09877 +0.60%33 Days Payable is 572.31 as of Dec. 2025, which is 31% below its 10-year median of 832.99. GuruFocus rates HKSE:09877 with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Jenscare Scientific Co ranks better than 95.21% on this metric.
The historical rank and industry rank for Jenscare Scientific Co's Days Payable or its related term are showing as below:
HKSE:09877'
s Days Payable Range Over the Past 10 Years
Min: 789.87 Med: 832.99 Max: 832.99
Current: 789.87
During the past 6 years, Jenscare Scientific Co's highest Days Payable was 832.99. The lowest was 789.87. And the median was 832.99.
HKSE:09877's Days Payable is ranked better than 95.21% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 68.615
vs HKSE:09877: 789.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:09877 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Jenscare Scientific Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jenscare Scientific Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Jenscare Scientific Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Jenscare Scientific Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jenscare Scientific Co (HKSE:09877) has a Days Payable of 572.31 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jenscare Scientific Co and its competitors. This is 31% below median its historical median of 832.99. Over the past decade, Jenscare Scientific Co's Days Payable has ranged from 789.87 to 832.99. According to the industry distribution chart, Jenscare Scientific Co ranks #38 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 4.8%.
Is Jenscare Scientific Co's Days Payable too high?
Jenscare Scientific Co's current Days Payable of 572.31 is 31% below median its 10-year median of 832.99. Over the past 10 years, this metric has ranged from a low of 789.87 to a high of 832.99. The Medical Devices & Instruments industry median Days Payable is 68.62. Jenscare Scientific Co's value of 572.31 is 734.1% above this industry median. Based on the distribution chart, Jenscare Scientific Co ranks #38 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Jenscare Scientific Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Jenscare Scientific Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Jenscare Scientific Co ranks #38 out of 794 companies for Days Payable. This places Jenscare Scientific Co in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.62. Jenscare Scientific Co's value of 572.31 is 734.1% above this benchmark. Historically, Jenscare Scientific Co's own Days Payable has ranged from 789.87 to 832.99 over the past decade. While the company's 10-year median is 832.99 vs. the industry median of 68.62, Jenscare Scientific Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.62, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jenscare Scientific Co's current Days Payable of 572.31 is 734.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jenscare Scientific Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jenscare Scientific Co's current Days Payable is 572.31, which is 31% below median its own 10-year median of 832.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jenscare Scientific Co stock overvalued right now?
Jenscare Scientific Co (HKSE:09877) has a current Days Payable of 572.31. The current Days Payable is 572.31, which is 31% below median its 10-year median of 832.99 and 734.1% above the Medical Devices & Instruments industry median of 68.62. Jenscare Scientific Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jenscare Scientific Co (HKSE:09877), the current Days Payable is 572.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
33GF Score
Get the complete analysis for HKSE:09877
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09877 has been successfully added to your 
